LYN and Chronic Eosinophilic Leukemia, Not Otherwise Specified: Taken together, these observations suggest that proliferation, survival, and migration in F/P-positive cells maybe depend on cellular Lyn kinase activity, and Lyn molecule can be an alternative feasible treatment target for imatinib-resistant CEL.